Clinical Trial Search Results

464 studies were found about Treatment Research, Treatment-Naive Patients
Filter Results: All Studies Studies seeking new volunteers Studies with results

Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected ARV Naïve Patients Treated With Darunavir/Ritonavir and Etravirine

Condition: Acute HIV Infection; HIV Infections

NCT ID: NCT00855413

Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients

Condition: Acquired Immune Deficiency Syndrome; HIV Infections

NCT ID: NCT00872417

Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects

Condition: HIV Infections

NCT ID: NCT01066962

The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00400738

Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults

Condition: HIV Infections; Antiretroviral Naive

NCT ID: NCT00196599

Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection

Condition: HIV Infections

NCT ID: NCT00959894

Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Condition: HIV; HIV Infections

NCT ID: NCT00869557

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT00993148

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01721109

Safety and Efficacy of Darunavir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Cobicistat-boosted Darunavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Fixed Dose Combination in HIV-1 Infected, Antiretroviral Treatment Naive Adults

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01565850

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Condition: HIV; HIV Infections

NCT ID: NCT01780506

Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Condition: HIV; HIV Infections

NCT ID: NCT01095796

Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Condition: HIV; HIV Infections

NCT ID: NCT01106586

Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults

Condition: HIV; HIV Infections

NCT ID: NCT01108510

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Condition: HIV Infections; HIV-1; Human Immunodeficiency Virus Type 1

NCT ID: NCT00540449

The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects

Condition: HIV Infections

NCT ID: NCT00540137

Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults

Condition: HIV-1 Infections

NCT ID: NCT00830804

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Condition: HIV Infections; HIV-1

NCT ID: NCT00543725

Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00762892

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

Condition: HIV Infections

NCT ID: NCT00654147

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01705574

Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen in HIV 1 Infected, Antiretroviral Treatment-Naive Adults

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01497899

Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection

Condition: Hepatitis B Virus; HIV Infections

NCT ID: NCT00476463

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Condition: Hiv Infection With Antiretroviral Therapy Indication; CD4 Below 350/µL or Below 15%

NCT ID: NCT00199979

Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects

Condition: HIV Infections

NCT ID: NCT00043966

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

Condition: Infection, Human Immunodeficiency Virus I; HIV-1 Infection

NCT ID: NCT00450580

Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus

Condition: HIV-1 Infection

NCT ID: NCT01338883

Kaletra and Viread in Antiretroviral Naïve Patients

Condition: HIV Infections

NCT ID: NCT00679926

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00039741

Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00945282

Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875AM5)(COMPLETED)

Condition: HIV Infections

NCT ID: NCT00551018

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With Ccr5 Tropic HIV 1

Condition: HIV-1

NCT ID: NCT01345630

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Condition: HIV Infection

NCT ID: NCT00234923

Safety and Efficacy of GS-9350-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Condition: HIV-1 Infection

NCT ID: NCT00892437

Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)

Condition: HIV Infections

NCT ID: NCT00525733

Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya

Condition: HIV Infections; Human Immunodeficiency Virus; Malaria; Plasmodium Falciparum; Diarrhea

NCT ID: NCT00914225

Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults.

Condition: HIV-1 Infection

NCT ID: NCT01309243

Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects

Condition: HIV Infections

NCT ID: NCT00350272

An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART

Condition: Human Immunodeficiency Virus; HIV

NCT ID: NCT01541085

Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00127959

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Condition: HIV Infection; Hepatitis C Infection

NCT ID: NCT00991289

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Condition: HIV Infections

NCT ID: NCT00102960

TMC310911-TiDP21-C201 - A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-naive HIV-1-infected Patients

Condition: HIV-1 Infections

NCT ID: NCT00838162

Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients

Condition: HIV Infections

NCT ID: NCT00752856

Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients

Condition: HIV Infections

NCT ID: NCT00677300

"The Once A Day Protease Inhibitor Regimens"

Condition: HIV Infections; Antiretroviral Therapy

NCT ID: NCT00242216

Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients

Condition: HIV-2 Infection

NCT ID: NCT01605890

Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive

Condition: HIV-1 Infection

NCT ID: NCT01489046

Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00820118

Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT01049685

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

Condition: HIV

NCT ID: NCT01275625

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users

Condition: HIV Infections; Hepatitis C

NCT ID: NCT01105611

A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients

Condition: HIV

NCT ID: NCT00199121

Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV Infection

Condition: HIV Infections

NCT ID: NCT01297127

A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients

Condition: HIV Infections

NCT ID: NCT00036634

Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients

Condition: HIV; Zidovudine Adverse Reaction

NCT ID: NCT01540240

TMC278-C204: TMC278 in Treatment Naive HIV-1 Infected Subjects

Condition: HIV Infection

NCT ID: NCT00110305

Boosted Atazanavir and Truvada Given Once-Daily - BATON Study

Condition: HIV Infections

NCT ID: NCT00224445

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01440569

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

Condition: HIV Infections

NCT ID: NCT00118898

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00740064

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial

Condition: HIV-1

NCT ID: NCT01192035

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00004578

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

Condition: HIV Infections

NCT ID: NCT00120185

R5 Integrase Study in HIV-1 Naive Patients

Condition: HIV Infections

NCT ID: NCT01204905

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

Condition: HIV Infections

NCT ID: NCT00530920

Early Access to TMC114/r and Other AVT for Treatment-naive or Early Treatment Experienced in HIV-1 Patients

Condition: HIV-1

NCT ID: NCT01702090

Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients

Condition: Human Immunodeficiency Virus

NCT ID: NCT00333892

A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002230

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal

Condition: HIV Infections

NCT ID: NCT00100568

A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT01638650

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00120510

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China

Condition: HIV Infections

NCT ID: NCT00100594

FREE Study: Efficacy and Toxicity of Trizivir

Condition: HIV Infections

NCT ID: NCT00405925

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents

Condition: HIV-1 Infection

NCT ID: NCT00915655

Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities

Condition: HIV Infections

NCT ID: NCT00255840

Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)

Condition: HIV Infections

NCT ID: NCT00660972

A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT)

Condition: HIV Infections

NCT ID: NCT00369941

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)

Condition: HIV Infections

NCT ID: NCT00207142

TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.

Condition: HIV

NCT ID: NCT00258557

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

Condition: HIV Infections

NCT ID: NCT00051831

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00427297

Intensive Viral Dynamics Substudy of A5248

Condition: HIV Infections; Treatment Naive

NCT ID: NCT00852618

Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects

Condition: Human Immunodeficiency Virus Infections

NCT ID: NCT00262522

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00039689

The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

Condition: HIV Infections; Papilloma

NCT ID: NCT00006444

Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00619944

Tenofovir in HIV/HBV Coinfection

Condition: HIV Infection; Hepatitis B Coinfection

NCT ID: NCT00192595

Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV

Condition: Tuberculosis; HIV

NCT ID: NCT01061593

A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

Condition: HIV Infections

NCT ID: NCT00001122

The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00411996

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Condition: HIV Infection

NCT ID: NCT00234910

Strategies for Delivering Anti-HIV Therapy in South Africa

Condition: HIV Infections

NCT ID: NCT00080522

Naïve HIV POC Monotherapy Trial

Condition: HIV Infections

NCT ID: NCT00617526

A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients

Condition: HIV Infections

NCT ID: NCT00002178

Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00112047

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

Condition: HIV Infections

NCT ID: NCT00931463

Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc/Lamivudine

Condition: HIV; Impaired Cognition

NCT ID: NCT01367236

Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

Condition: HIV Infections

NCT ID: NCT00158821

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Condition: HIV Infections

NCT ID: NCT00084136

A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).

Condition: HIV-1 Infection

NCT ID: NCT00534352

Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals.

Condition: HIV Infections

NCT ID: NCT01011413

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

Condition: HIV Infection

NCT ID: NCT00711230

A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1

Condition: HIV-1

NCT ID: NCT00824421

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Condition: HIV

NCT ID: NCT01236235

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes

Condition: HIV Infections

NCT ID: NCT00389402

Succinylated Human Serum Albumin (Suc-HSA) for HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00128063

GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00105079

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00043953

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Condition: HIV Infections

NCT ID: NCT00050895

A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)

Condition: HIV

NCT ID: NCT00745823

A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance

Condition: HIV; HIV Infections

NCT ID: NCT01042652

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437476

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

Condition: Human Immunodeficiency Virus-1

NCT ID: NCT00827112

Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00393120

A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients

Condition: HIV Infection; HIV; Acquired Immunodeficiency Syndrome

NCT ID: NCT00903682

Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC

Condition: HIV

NCT ID: NCT01620944

Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir

Condition: HIV Infections

NCT ID: NCT00214890

Europe-Africa Research Network for Evaluation of Second-line Therapy

Condition: Human Immunodeficiency Virus; HIV

NCT ID: NCT00988039

High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk

Condition: HIV-related Lymphoma; HIV Infections

NCT ID: NCT01045889

Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)

Condition: HIV Infection

NCT ID: NCT00120419

ALCAR Prophylaxis Study

Condition: HIV Infections; Distal Symmetric Polyneuropathy

NCT ID: NCT00225160

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

Condition: HIV-1 Infection

NCT ID: NCT01772940

Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00647205

Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals

Condition: HIV Infection

NCT ID: NCT01433289

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

Condition: HIV Infection

NCT ID: NCT00244712

Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism

Condition: HIV Infections

NCT ID: NCT00759070

Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment

Condition: HIV

NCT ID: NCT00757783

Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)

Condition: HIV Infection

NCT ID: NCT00158457

Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors

Condition: HIV Infection

NCT ID: NCT01474954

TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously

Condition: HIV Infections

NCT ID: NCT00513513

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

Condition: HIV Infections

NCT ID: NCT00449436

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

Condition: HIV Infections; Treatment Naive

NCT ID: NCT00851799

Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection; HIV-1 Infection

NCT ID: NCT00481390

Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00135460

Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl

Condition: HIV Infections

NCT ID: NCT00532168

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00428116

Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease

Condition: Acquired Immune Deficiency Syndrome

NCT ID: NCT00775606

Comparative Study of Three NNRTI-Sparing HAART Regimens

Condition: HIV Infection

NCT ID: NCT00811954

Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment

Condition: HIV Infections

NCT ID: NCT00544128

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients

Condition: HIV Infections; Hepatitis C, Chronic; Treatment Failure

NCT ID: NCT00221650

The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)

Condition: HIV Infection

NCT ID: NCT01271894

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT00711009

Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.

Condition: HIV Infection

NCT ID: NCT00386659

Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon

Condition: HIV Infections

NCT ID: NCT00658346

Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection

Condition: HIV

NCT ID: NCT01343225

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00966160

Controlling Acute or Early HIV Infection With Antiretroviral Drugs, With or Without a Candidate Vaccine

Condition: HIV Infections

NCT ID: NCT00238459

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

Condition: HIV Infections; AIDS

NCT ID: NCT00302822

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Condition: HIV

NCT ID: NCT01605084

A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection

Condition: Human Immunodeficiency Virus Type 1 (HIV-1) Infection

NCT ID: NCT01692470

Response to Standard HIV Treatment in Bamako, Mali

Condition: HIV Infections

NCT ID: NCT00703404

Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100

Condition: HIV Infections

NCT ID: NCT00385957

Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients

Condition: HIV Infections

NCT ID: NCT00084253

Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Condition: HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders

NCT ID: NCT00119405

Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)

Condition: HIV Infections

NCT ID: NCT01068873

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment

Condition: HIV Infection

NCT ID: NCT00280969

The Neurocognitive Sub-study of Encore1

Condition: HIV

NCT ID: NCT01516060

Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV

Condition: HIV Infections; Atherosclerosis

NCT ID: NCT00575939

Safety Sudy of Atazanavir Capsules in the Treatment of HIV in Patients Ages 6 - 18 Years

Condition: HIV, Pediatric

NCT ID: NCT01691794

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00393276

Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania

Condition: Malaria, Falciparum; HIV Infections

NCT ID: NCT00885287

Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa

Condition: Cryptococcal Meningitis; HIV Infections

NCT ID: NCT00830856

Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects

Condition: HIV Infection

NCT ID: NCT00096746

Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis

Condition: HIV Infection; Osteopenia; Osteoporosis

NCT ID: NCT01020045

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects

Condition: Chronic Hepatitis C; Human Immunodeficiency Virus

NCT ID: NCT01783678

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

Condition: HIV Infections

NCT ID: NCT00491556

The VMVN Study: Virological Monitoring in Viet Nam

Condition: HIV Infection; AIDS

NCT ID: NCT01317498

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults

Condition: HIV Infections

NCT ID: NCT00389207

Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals

Condition: HIV Infections

NCT ID: NCT00632970

Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00005000

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy

Condition: HIV-1 Infection

NCT ID: NCT00709397

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy

Condition: HIV Infections

NCT ID: NCT00004583

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002411

A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects

Condition: HIV Infections

NCT ID: NCT01045369

Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients

Condition: HIV

NCT ID: NCT01269515

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002168

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of TMC278 in Human Immunodeficiency Virus Infected Adolescents

Condition: Human Immuno Deficiency (HIV) Infections

NCT ID: NCT00799864

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002369

Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand

Condition: HIV Infections

NCT ID: NCT00162682

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002451

Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen

Condition: HIV; Hypercholesterolemia; Dyslipidemia

NCT ID: NCT01705873

A Study to Explore Reconstitution of Immunity in Patients With Advanced HIV-1-infection

Condition: HIV Immune Restoration

NCT ID: NCT01296373

Antiretroviral Therapy for Advanced HIV Disease in South Africa

Condition: HIV

NCT ID: NCT00342355

Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

Condition: This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy.

NCT ID: NCT01225406

A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01499199

Once-Daily Drug Regimen for HIV-Infected Patients

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00001968

An Observational Study of People Who Have Recently Been Infected With HIV

Condition: HIV Infections

NCT ID: NCT00103961

Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00016588

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00549198

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01449929

Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00004998

A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002440

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00002216

Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

Condition: HIV Infections

NCT ID: NCT00005002

A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002407

Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00004852

Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00004999

Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring Trials

Condition: HIV Infections

NCT ID: NCT01618058

HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia

Condition: HIV Infections

NCT ID: NCT00777426

A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy

Condition: HIV Infection

NCT ID: NCT00053638

Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults

Condition: Malaria; HIV

NCT ID: NCT00790881

Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00004855

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

Condition: HIV Infections; Diffuse Large B Cell Lymphoma

NCT ID: NCT00466258

A Dose-Ranging Study to Compare MK-1439 Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007 AM9)

Condition: HIV Infections

NCT ID: NCT01632345

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01059422

Safety of Raltegravir When Given as Part of HIV Therapy in HIV/HCV Coinfected Individuals

Condition: HIV/ Hepatitis C Co-Infection

NCT ID: NCT01147107

Phase IIB Pilot of Atazanavir + Raltegravir

Condition: HIV

NCT ID: NCT00768989

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana

Condition: Tuberculosis; HIV

NCT ID: NCT01687504

Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet

Condition: Human Immunodeficiency Virus

NCT ID: NCT01097655

Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients

Condition: HIV

NCT ID: NCT01291459

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00983853

Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV)

Condition: HIV; HIV Infections

NCT ID: NCT00858923

HIV Viral Load Monitoring in Resource-Poor Settings

Condition: HIV; AIDS; HIV Infections

NCT ID: NCT00929604

Minocycline for HIV+ Cognitive Impairment in Uganda

Condition: HIV-associated Cognitive Impairment; HIV Infections

NCT ID: NCT00855062

Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men

Condition: HIV Infection; Cardiovascular Risk; HIV Infections

NCT ID: NCT00846599

Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia

Condition: HIV; Contraception; HIV Infections

NCT ID: NCT00807625

Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients

Condition: Immune Reconstitution Inflammatory Syndrome; HIV; HIV Infections

NCT ID: NCT00988780

Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial

Condition: HIV Infection; Pregnancy; Breastfeeding; HIV Infections

NCT ID: NCT00936195

The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1

Condition: HIV Infection

NCT ID: NCT01451333

Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection

Condition: HIV -1 Infection; HIV Infections

NCT ID: NCT00642707

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00426296

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals With Herpes Simplex Virus Type 2?

Condition: HIV Infection; Herpesvirus 2, Human; HIV Infections

NCT ID: NCT00860977

Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission

Condition: Disease Transmission, Vertical; Vertical Human Immunodeficiency Virus Transmission; HIV Infections

NCT ID: NCT00099359

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Inmunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Condition: Hepatitis C, Chronic

NCT ID: NCT01399619

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01363011

Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection

Condition: HIV Infections

NCT ID: NCT00006443

Safety Study of Once a Day ART and Opiate Substitute.

Condition: HIV Infections

NCT ID: NCT00324688

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-Infected Persons

Condition: HIV Infections; Herpes Simplex; Sexually Transmitted Diseases

NCT ID: NCT00465205

Raltegravir Activity In Lymphoid Tissues

Condition: HIV Infection; HIV Infections

NCT ID: NCT00863668

Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine

Condition: HIV Infections

NCT ID: NCT00808002

Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST)

Condition: HIV; Tuberculosis

NCT ID: NCT00851630

Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection

Condition: HIV Infections

NCT ID: NCT00856154

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Condition: Hepatitis; HIV/AIDS

NCT ID: NCT01443923

Anti-HIV Medications for People Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00106171

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

Condition: HIV Infection; Herpes Simplex, Genital; Sexually Transmitted Diseases

NCT ID: NCT00194519

A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00000922

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

Condition: HIV Infections

NCT ID: NCT00006604

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00051090

Social and Economic Outcomes of HIV/AIDS Care and Treatment in HIV Infected South African Adults

Condition: HIV Infections

NCT ID: NCT00270764

A Study of HIV-infected Subjects Initiating Anti-HIV Drugs for the First Time

Condition: HIV Infections

NCT ID: NCT00595192

Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00050908

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00108862

The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV

Condition: HIV Infections

NCT ID: NCT00004735

Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00084032

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Condition: HIV Infections

NCT ID: NCT00109590

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Condition: HIV Infections; Herpesvirus 2, Human

NCT ID: NCT00371592

A Study of Anti-HIV Monoclonal Antibody KD-247

Condition: HIV Infections

NCT ID: NCT00917813

A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both

Condition: HIV Infections; TB

NCT ID: NCT00480558

Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?

Condition: HIV Infections; Helminthiasis

NCT ID: NCT00817713

Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00016718

Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding

Condition: HIV Infections

NCT ID: NCT00074412

Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation

Condition: HIV Infections; Helminthiasis

NCT ID: NCT00130910

Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of Chloroquine

Condition: HIV Infections

NCT ID: NCT00308620

Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected People

Condition: HIV Infection

NCT ID: NCT00919724

Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00100633

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00110578

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00307151

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV

Condition: Genital Herpes; HIV Infection

NCT ID: NCT00527618

Effects of HIV and Hepatitis C Virus on the Brain

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00494936

Metabolic Abnormalities - HIV Infected and Uninfected Males

Condition: HIV Infections

NCT ID: NCT00260936

Enhancing Oral Health Care Use by HIV Positive Individuals

Condition: Oral Hygiene; HIV Infections; Mouth Diseases

NCT ID: NCT00444977

Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals

Condition: HIV Infection; CMV Infection

NCT ID: NCT00168259

Nutrition Intervention in Drug Naive HIV-infected Kenyan Women and Their Children

Condition: HIV Infections

NCT ID: NCT00562874

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

Condition: HIV Infections; Herpes Genitalis

NCT ID: NCT00405821

Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania

Condition: HIV Infections

NCT ID: NCT00523510

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Condition: HIV Infections

NCT ID: NCT00013520

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Condition: HIV Infections; AIDS-Related Opportunistic Infections

NCT ID: NCT00055120

The Effect of Malaria on Disease Progression of HIV/AIDS

Condition: HIV Infections; Malaria

NCT ID: NCT00499876

Oral Human Papillomavirus Infection in HIV-Infected Men

Condition: Papillomavirus Infections; HIV Infections

NCT ID: NCT00421486

Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00517569

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

Condition: HIV Infections; Pregnancy

NCT ID: NCT00017719

Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients

Condition: HIV Infections

NCT ID: NCT01067417

Pioglitazone to Treat Fatty Liver in People With HIV Infection

Condition: HIV Infections; Hepatic Steatosis; Insulin Resistance

NCT ID: NCT00441272

Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00115609

A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00398996

Induction-Maintenance of Lopinavir/r in HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00159224

The Effects of Nutritional Supplementation and Drug Abuse on HIV

Condition: HIV Infections; Substance-Related Disorders

NCT ID: NCT00149656

Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)

Condition: HIV Infections

NCT ID: NCT00122603

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

Condition: HIV Infections

NCT ID: NCT00116636

Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV

Condition: HIV Infection; Tuberculosis; Pneumocystis Jiroveci Pneumonia

NCT ID: NCT00080119

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Condition: HIV Infections; Dyslipidemias; Glucose Metabolism Disorders; Metabolic Diseases; Lipodystrophy; Cardiovascular Disease

NCT ID: NCT00192621

Trial of Zinc and HIV Progression in Children

Condition: HIV Infections

NCT ID: NCT00446758

Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men

Condition: Anus Neoplasms; HIV Infections

NCT ID: NCT00428285

A Prospective Cohort of Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00476606

The Role of Naive T-Cells in HIV Pathogenesis

Condition: HIV Infections

NCT ID: NCT00206531

Management of Hepatitis C in HIV-Infected and Uninfected IDUs

Condition: Hepatitis C Virus; HIV Infections

NCT ID: NCT00496912

HIV Resistance and Treatment Strategies

Condition: HIV Infections

NCT ID: NCT00581802

Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers

Condition: HIV Infections

NCT ID: NCT00164762

Impact of HIV and Its Treatment on Reverse Cholesterol Transport

Condition: HIV Infections

NCT ID: NCT00168233

Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV

Condition: HIV Infections

NCT ID: NCT00432016

Effectiveness of Antiretroviral Therapy During Acute HIV Infection

Condition: HIV Infections

NCT ID: NCT00705926

Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy

Condition: HIV Infection

NCT ID: NCT00009256

Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression

Condition: HIV Infections; Helminthiasis

NCT ID: NCT00507221

Pain and Sensory Changes Assessment in HIV+ Patients

Condition: HIV Infections

NCT ID: NCT00422695

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00848211

The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk

Condition: HIV Infection; Cardiovascular Disease; Inflammation

NCT ID: NCT01333644

Raltegravir as Early Therapy in African-Americans Living With HIV Study

Condition: HIV Infections

NCT ID: NCT00667433

Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

Condition: HIV Infections

NCT ID: NCT00885664

Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00474435

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00270296

Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis

Condition: Cryptococcal Meningitis; HIV Infections

NCT ID: NCT00976040

Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00226434

Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)

Condition: HIV Infections; AIDS

NCT ID: NCT00122538

Effect of Medication Diaries on Adherence to Highly Active Antiretroviral Drugs Among HIV-1 Infected Kenyan Children

Condition: HIV Infections

NCT ID: NCT00194545

The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients

Condition: HIV Infections; Diarrhea; Bacterial Vaginosis

NCT ID: NCT00536848

Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)

Condition: HIV Infections

NCT ID: NCT00158405

Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals

Condition: HIV Infections

NCT ID: NCT00428519

A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly

Condition: HIV Infections

NCT ID: NCT00001129

Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.

Condition: HIV Infections

NCT ID: NCT00148824

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00086359

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00822315

Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

Condition: HIV Infection

NCT ID: NCT00234962

Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose

Condition: HIV Infection

NCT ID: NCT01300988

Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients

Condition: HIV Infections

NCT ID: NCT00106379

Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT00114699

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada

Condition: HIV Infections

NCT ID: NCT00528060

An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals

Condition: HIV Infections; HCV

NCT ID: NCT00489385

Genotype Based Personalized Prescription of Nevirapine

Condition: Nevirapine Induced Rash; Nevirapine Induced Hepatitis; HIV; Adverse Side Effects; AIDS; HIV Infections

NCT ID: NCT00986063

Three Month Course of Anti-HIV Medications for People Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00087464

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00090779

Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00089466

Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00075907

Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis

Condition: HIV Infections; Tuberculous Meningitis

NCT ID: NCT00433719

Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)

Condition: HIV-1 Infections

NCT ID: NCT01033760

Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

Condition: HIV

NCT ID: NCT00634959

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Condition: HIV Infections

NCT ID: NCT00234091

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00100581

PREventing Progression of Adipose Tissue Redistribution

Condition: HIV Infections

NCT ID: NCT00389194

Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People

Condition: HIV Infections

NCT ID: NCT00110812

Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00091936

Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00920426

PRO 140 by IV Administration in Adults With HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00613379

Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV

Condition: HIV Infections

NCT ID: NCT00256828

Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

Condition: HIV Infections

NCT ID: NCT00643643

Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission

Condition: HIV Infections

NCT ID: NCT00084045

Treatment of Acute HIV Infection to Preserve Immune Function

Condition: HIV Infections

NCT ID: NCT00055094

Zinc Therapy in HIV Infected Individuals Who Abuse Drugs

Condition: HIV Infections; Substance-Related Disorders

NCT ID: NCT00149552

Directly Observed Therapy for HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00259389

Metabolic Abnormalities in HIV Infected and Uninfected Young Women

Condition: HIV Infections; Hypercholesterolemia; Glucose Intolerance

NCT ID: NCT00067587

Psychiatric Problems in Children and Adolescents Infected With HIV at Birth

Condition: HIV Infections; Mental Disorders

NCT ID: NCT00100542

Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials

Condition: HIV Infections

NCT ID: NCT00514098

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

Condition: Hepatitis C Virus; Hiv Infections

NCT ID: NCT00503347

Long-term Follow-up of HIV Infected Patients Identified During Early Infection

Condition: HIV Infections

NCT ID: NCT00086372

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

Condition: HIV Infections; Pregnancy

NCT ID: NCT00125983

A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.

Condition: HIV Infections

NCT ID: NCT00435929

Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)

Condition: HIV Infections; Sexually Transmitted Diseases

NCT ID: NCT00146419

Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT01482767

NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission

Condition: HIV Infections

NCT ID: NCT00089505

Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People

Condition: HIV Infections

NCT ID: NCT00078442

A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, China

Condition: HIV Infections

NCT ID: NCT00479141

Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals

Condition: HIV Infections

NCT ID: NCT00272493

Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy

Condition: HIV Infections

NCT ID: NCT00099632

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)

Condition: Tuberculosis; Aids; Hiv Infections

NCT ID: NCT00495326

Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring

Condition: Acquired Immunodeficiency Syndrome; Resistance

NCT ID: NCT00434070

A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175

Condition: HIV Infections

NCT ID: NCT00096824

A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00075231

Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection

Condition: HIV Infections

NCT ID: NCT00084149

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

Condition: HIV Infection; Hepatitis C

NCT ID: NCT00121017

Tissue Drug Levels of HIV Medications

Condition: Human Immunodeficiency Virus

NCT ID: NCT01490346

Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen

Condition: HIV-1 Infection

NCT ID: NCT01400412

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Condition: Chronic Hepatitis C

NCT ID: NCT01513941

NRTI-Sparing Pilot Study

Condition: HIV; Mitochondrial Toxicity

NCT ID: NCT00143689

A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

Condition: HIV Infections

NCT ID: NCT00036452

Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication

Condition: HIV Infections

NCT ID: NCT00006578

FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir

Condition: HIV-1 Infection

NCT ID: NCT01777997

A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00523458

Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients

Condition: HIV; Tuberculosis; Latent Tuberculosis Infection

NCT ID: NCT00805272

Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients

Condition: HIV

NCT ID: NCT00299091

Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa

Condition: HIV Infections

NCT ID: NCT00100646

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00476853

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00545558

Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine

Condition: HIV-1

NCT ID: NCT00098293

Supportive Therapy for Adherence to ART(STAART)

Condition: HIV Infections

NCT ID: NCT00212940

Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART

Condition: HIV

NCT ID: NCT00516581

Durability of Nevirapine-Based Antiretroviral Regimen

Condition: HIV Infections

NCT ID: NCT00703898

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Condition: HIV Infections

NCT ID: NCT00272779

Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)

Condition: HIV Infection

NCT ID: NCT00158470

Evaluation and Monitoring of Patients With HIV Infectionn

Condition: HIV

NCT ID: NCT00557570

A Phase 2 Study Of PF-00232798 In HIV Positive Patients

Condition: HIV

NCT ID: NCT00495677

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

Condition: HIV Infection; Infection, Human Immunodeficiency Virus; HIV-1 Infection

NCT ID: NCT00951015

Strategic Timing of Antiretroviral Treatment

Condition: HIV Infection

NCT ID: NCT00867048

A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy

Condition: HIV Infections

NCT ID: NCT00870363

Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

Condition: HIV Infections

NCT ID: NCT00001137

An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00408642

Pharmacokinetics Study on Nevirapine Resistance in Tanzania

Condition: HIV Infections

NCT ID: NCT00294892

Pediatric Nevirapine Resistance Study

Condition: AIDS; HIV Infections

NCT ID: NCT00117728

An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment

Condition: HIV Infections

NCT ID: NCT00675844

Bone Mineral Density (BMD) in HIV Infection

Condition: Osteopenia; Osteoporosis

NCT ID: NCT00146094

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort

Condition: HIV Infections

NCT ID: NCT00618176

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00440947

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Condition: HIV Infection

NCT ID: NCT00326716

Safety of the HIV Vaccine 732461 in HIV Infected Subjects Aged 18 to 55 Years Old

Condition: HIV (Human Immunodeficiency Virus)-Infected Adults

NCT ID: NCT00814762

Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)

Condition: HIV Infections; AIDS

NCT ID: NCT00301561

Increasing HAART-Induced Immune Restoration With Cyclosporine

Condition: HIV Infections

NCT ID: NCT00031070

Anti-Retrovirals for Kaposi's Sarcoma

Condition: Kaposi's Sarcoma; HIV Infections

NCT ID: NCT00444379

Neurocognitive Assessment in Youth Initiating HAART

Condition: HIV Infections

NCT ID: NCT00683579

Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00533390

Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients

Condition: HIV Infections

NCT ID: NCT00752037

GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults

Condition: Human Immunodeficiency Virus I Infection; HIV Infection

NCT ID: NCT00257621

ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT00335322

Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events

Condition: HIV-Infection

NCT ID: NCT01417949

Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients

Condition: HIV Infection; Atherosclerosis

NCT ID: NCT00247494

Longitudinal Study of HAART, Social Networks, & Adherence

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00272220

Bone Mineral Density in HIV+ Patients

Condition: Bone Mineral Density; Bone; Osteoporosis

NCT ID: NCT01378494

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00483054

Impact of Nutrition Intervention on HIV/AIDS Infected Patients

Condition: Human Immunodeficiency Virus (HIV); Acquired Immune Deficiency Syndrome (AIDS)

NCT ID: NCT01171495

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)

Condition: HIV; HIV Infections

NCT ID: NCT00928187

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects

Condition: Hepatitis C,; Human Immunodeficiency Virus

NCT ID: NCT01667731

In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults

Condition: Malaria; HIV; AIDS

NCT ID: NCT00144352

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01263015

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

Condition: Malaria; HIV Infections

NCT ID: NCT00978068

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01641809

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

Condition: HIV Infection

NCT ID: NCT00001445

A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)

Condition: HIV

NCT ID: NCT01445223

A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00006190

To Evaluate Effectiveness and Safety of Containing Raltegravir in Naive HIV NON B or B Infected Patients

Condition: Evaluated; Non B Subtype; Naive Patients

NCT ID: NCT01162538

Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00620438

Immune Reconstitution in HIV Disease (IREHIV)

Condition: HIV Infection

NCT ID: NCT01702974

Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India

Condition: HIV Infections; Heroin Dependence

NCT ID: NCT00709007

An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects

Condition: HIV Infections

NCT ID: NCT00642291

The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001057

Cryptococcal Optimal ART Timing Trial

Condition: Cryptococcal Meningitis; HIV Infections; AIDS

NCT ID: NCT01075152

Impact of Immediate Versus WHO Recommendations Guided ART Initiation on HIV Incidence - Feasibility Phase

Condition: HIV Infection

NCT ID: NCT01509508

Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients

Condition: HIV-1 Infection; AIDS

NCT ID: NCT01348308

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

Condition: HIV Infections; Lymphoma, Non-Hodgkin

NCT ID: NCT00432419

ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla

Condition: HIV Infections

NCT ID: NCT00615745

A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells

Condition: HIV Infections; Acquired Immune Deficiency Syndrome

NCT ID: NCT01173510

A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP

Condition: HIV Infections

NCT ID: NCT00669487

Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor

Condition: HIV Infections

NCT ID: NCT00041769

CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery

Condition: HIV Infections

NCT ID: NCT00925756

Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults

Condition: Tuberculosis

NCT ID: NCT01262976

Vaginal Innate Immunity in Normal and HIV-Infected Women

Condition: HIV; Pregnancy

NCT ID: NCT01318304

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00098748

NOW Thai HAART Study

Condition: HIV; AIDS; Neurological Complications

NCT ID: NCT00367731

DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects

Condition: HIV

NCT ID: NCT01423812

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Condition: HIV

NCT ID: NCT01255371

Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation

Condition: Renal Function; HIV Infection

NCT ID: NCT01138241

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)

Condition: Tuberculosis; HIV

NCT ID: NCT01637558

Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients

Condition: HIV Infection

NCT ID: NCT01359800

Chinese Network of Pediatric Antiretroviral Therapy

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT01210924

Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract

Condition: Women's Health; HIV Infection; Genital Diseases, Female

NCT ID: NCT01456962

Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT01366547

Evaluation of the Bioequivalence of a Combined Formulated Tablet

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01622790

Drug Exposure Registry for GSK2248761, an Investigational NNRTI

Condition: Seizures; Infection, Human Immunodeficiency Virus

NCT ID: NCT01458132

A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine

Condition: HIV

NCT ID: NCT01701882

A Study of the Long-Term Outcomes of HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00000932

A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients

Condition: Human Immunodeficiency Virus-Type 1

NCT ID: NCT01726348

Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia

Condition: HIV Infections

NCT ID: NCT00753324

A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista

Condition: Acquired Immune Deficiency Syndrome

NCT ID: NCT01741831

Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz

Condition: HIV Infections

NCT ID: NCT01160120

Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe

Condition: HIV Infection

NCT ID: NCT01389310

HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections

Condition: Human Immunodeficiency Virus-1

NCT ID: NCT01384734

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Condition: HIV

NCT ID: NCT01335698

An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection

Condition: HIV Infection

NCT ID: NCT00162227

An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada

Condition: HIV Infection

NCT ID: NCT00162188

Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus

Condition: Hepatitis C, Genotype 1

NCT ID: NCT01471574

Atazanavir/Ritonavir (ATV/RTV) Once a Day (QD) + Raltegravir (RAL) Twice a Day (BID) Stable Switch Study

Condition: HIV, Combination Therapy

NCT ID: NCT01332227

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Condition: Tuberculosis

NCT ID: NCT01222338

Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.

Condition: AIDS

NCT ID: NCT01344148

Korean Post-marketing Surveillance for Reyataz®

Condition: HIV-1

NCT ID: NCT01450605

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

Condition: Chronic Hepatitis C; Chronic Hepatitis B

NCT ID: NCT00225537

Unboosted Atazanavir as Initial ART Therapy in China

Condition: Antiretroviral Therapy

NCT ID: NCT01459575